Passage Bio, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Passage Bio, Inc. | PASG - NASDAQ |
$16.00-$18.00 | $18.00 | $22.27 | 12 million | 2/28/2020 |
| JP Morgan, Goldman Sachs, Cowen | ||||||
Co-Manager(s): Chardan | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-02-03 Terms Added 2020-02-18 Free Writing Prospectus 2020-02-20 Terms Changed 2020-02-27 | ||||||
Passage Bio, Inc. Quote & Chart - Click for current quote - PASG
IPO Boutique aggregates information on public companies and private companies, such as "PASG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Passage Bio, Inc. (adapted from Passage Bio, Inc. prospectus):
They are a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system, or CNS, disorders with limited or no approved treatment options.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system, or CNS, disorders with limited or no approved treatment options.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "PASG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.